Filing Details

Accession Number:
0001140361-15-010559
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-05 17:34:16
Reporting Period:
2015-03-03
Filing Date:
2015-03-05
Accepted Time:
2015-03-05 17:34:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1114913 Pierre Lapalme C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-03 10,000 $11.15 40,150 No 4 M Direct
Common Stock Acquisiton 2015-03-03 10,000 $17.33 50,150 No 4 M Direct
Common Stock Disposition 2015-03-03 20,000 $106.57 30,150 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy Common Stock) Disposition 2015-03-03 10,000 $0.00 10,000 $11.15
Common Stock Stock Option (right to buy Common Stock) Disposition 2015-03-03 10,000 $0.00 10,000 $17.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-07-27 2016-01-26 No 4 M Direct
12,500 2007-12-07 2017-06-06 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,500 Indirect Shares held by spouse
Footnotes
  1. The price in column 4 is an average weighted price. The price actually received ranged from $106.20 to 106.895. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
  2. Original option grant vests 6/48ths on July 27, 2006, and 1/48th on the 27th of each month thereafter.
  3. Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
  4. Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th of each month thereafter.